BKM Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.19M Buy
16,493
+3,523
+27% +$821K 1.48% 18
2026
Q1
$3.17M Sell
12,970
-4,172
-24% -$972K 1.16% 23
2025
Q4
$3.55M Buy
17,142
+2,643
+18% +$523K 1.3% 20
2025
Q3
$2.69M Sell
14,499
-533
-4% -$91.3K 0.99% 26
2025
Q2
$2.3M Sell
15,032
-121
-0.8% -$18.6K 0.9% 31
2025
Q1
$2.51M Buy
15,153
+629
+4% +$98.4K 1.03% 27
2024
Q4
$2.1M Buy
14,524
+212
+1% +$32.9K 0.86% 30
2024
Q3
$2.32M Buy
14,312
+78
+0.5% +$12.4K 0.94% 25
2024
Q2
$2.08M Sell
14,234
-239
-2% -$35.5K 1% 27
2024
Q1
$2.29M Buy
14,473
+2,025
+16% +$322K 0.98% 24
2023
Q4
$1.95M Buy
+12,448
New +$1.91M 0.83% 27

Other funds holding JNJ

BKM Wealth Management's JNJ Position: Q2 2026 in Review

BKM Wealth Management increased its Johnson & Johnson (JNJ) stake by 27% in Q2 2026, buying an estimated $821K and bringing the position to 16,493 shares worth $4.19M. The position accounts for 1.48% of the portfolio, ranked #18.

BKM Wealth Management first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 4,689 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • BKM Wealth Management held 16,493 shares of Johnson & Johnson worth $4.19M as of Q2 2026.
  • BKM Wealth Management bought 3,523 Johnson & Johnson shares in Q2 2026, an estimated $821K.
  • Johnson & Johnson made up 1.48% of BKM Wealth Management's portfolio in Q2 2026, its #18 holding.
  • BKM Wealth Management first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 4,689 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on BKM Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.